None at this time.


2022 Educational Program

Learn more about the topics and speakers we are working on!

ACS Calls for Urgent Action to Address US Firearm Violence Epidemic

In response to recent and continuing firearm violence, the ACS hosted a recent news conference during which leaders of the organization reiterated their commitment to collaborating with lawmakers and communities with the goal of addressing this public health epidemic.

Help Support Victims of the Humanitarian Crisis in Ukraine

Your help is sincerely appreciated.

The ACS is supporting education efforts to ensure citizens of Ukraine know the basics of the STOP THE BLEED® course so that they can implement these lifesaving techniques when needed. Find out More.

Forgotten on the Frontlines

Healthcare’s labor shortage amid the pandemic is leading to stress and burnout among nurses as they seek early retirement, accept temporary travel jobs or change careers

Black Women and Breast Cancer: Experts Discuss Shortcomings in Care

Article in General Surgery News

“Black women have more aggressive breast cancer at a young age than other women, and they’re more likely to die at a young age from these cancers. But they don’t have the same opportunities for screening, genetic testing, treatment and clinical trial participation, experts in oncology reported during a panel session at the 2021 Clinical Congress of the American College of Surgeons.”

Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine

Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.

"While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future," Pfizer Senior Vice President and Head of Vaccine Research and Development Kathrin Jansen said in the release.

How the National Blood Shortage Will Affect Nearly Everyone: What You Can Do

Healthline (1-13-2022)

In a joint statement this week with America’s Blood Centers and the Association for the Advancement of Blood & Biotherapies, the organization said, “If the nation’s blood supply doesn’t stabilize soon, lifesaving blood may not be available for some patients when it is needed.” In the past few weeks, the Red Cross, which supplies approximately 40 percent of the nation’s blood, has had to limit blood distributions to hospitals.

Do the Omicron Numbers Mean What We Think They Mean?

The New Yorker (1-16-2022)

A coronavirus infection isn’t what it once was. Studies suggest that, compared with Delta, Omicron is a third to half as likely to send someone to the hospital; by some estimates, the chance that an older, vaccinated person will die of covid is now lower than the risk posed by the seasonal flu. And yet the variant is exacting a punishing toll—medical, social, economic.